The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21
Open accessAbstract
The fibroblast growth factor (FGF) 19 subfamily of ligands, FGF19, FGF21, and FGF23, function as hormones that regulate bile acid, fatty acid, glucose, and phosphate metabolism in target organs through activating FGF receptors (FGFR1-4). We demonstrated that Klotho and betaKlotho, homologous single-pass transmembrane proteins that bind to FGFRs, are required for metabolic activity of FGF23 and FGF21, respectively. Here we show that, like FGF21, FGF19 also requires betaKlotho. Both FGF19 and FGF21 can signal through FGFR1-3 bound by betaKlotho and increase glucose uptake in adipocytes expressing FGFR1. Additionally, both FGF19 and FGF21 bind to the betaKlotho-FGFR4 complex; however, only FGF19 signals efficiently through FGFR4. Accordingly, FGF19, but not FGF21, activates FGF signaling in hepatocytes that primarily express FGFR4 and reduces transcription of CYP7A1 that encodes the rate-limiting enzyme for bile acid synthesis. We conclude that the expression of betaKlotho, in combination with particular FGFR isoforms, determines the tissue-specific metabolic activities of FGF19 and FGF21.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“loss of KLB abolishes all effects of FGF21 in vitro and in vivo46,53–56.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 binding promotes the formation of a dimeric FGFR1c–KLB signalling complex, which activates the intracellular tyrosine kinase domains of FGFR1c and propagates signalling through phosphorylation by the kinase ERK46,53,58,59”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 elicits its biological effects by binding and activating a receptor complex composed of the co-receptor KLB and a traditional FGF receptor, fibroblast growth factor receptor 1c (FGFR1c)46,47.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“Interestingly, both FGF21 and another endocrine FGF, FGF15/19, share a requirement for KLB for signaling46,54, but what cross-talk, if any, exists between these signalling pathways in both physiological and pharmacological settings is unclear.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 signals to a receptor complex comprised of FGF receptor 1c (FGFR1c) and its co-receptor β-klotho (KLB) [[143], [144], [145], [146]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [143]
In the citing paper
“Importantly, since FGF receptors are ubiquitously expressed, endocrine FGFs require a coreceptor to provide signaling specificity, which for FGF21 and FGF19 is the coreceptor β-klotho (71, 99, 140).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [71]
In the citing paper
“FGF21 functions in target tissues that express the traditional FGF receptor FGFR1c and the obligate coreceptor β-klotho (2, 27, 71, 99, 124, 140).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Self-citationFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Self-citationReceptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Self-citationKlotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,865
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationShimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,503
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K., Evans, W. E., O'Riordan, J., Speer, M., Econs, M., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,467
Cited by
Sorted by citations
Items 601–700 of 748
FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbens
Cooley, B. J., Brown, C., Choi, E. A., Heller, W. A., LIM, A., Lawrence, A. J., Haber, P., McNally, G. P., & Millan, E. Z. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02133-z · Cited by 6
Luo, W., Lin, X., Wang, T., Cai, J., Zeng, X., Zhu, C., Li, R., Wang, H., & Wu, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26780 · Cited by 6
Zhang, Y., Le, Y., Ji, Y., Yarde, S., Yu, X., & Cheng, X. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114823 · Cited by 6
Kiani, B., Yarahmadi, S., Nabi‐Afjadi, M., Eskandari, H., Hasani, M., Abbasian, Z., & Bahreini, E. (2022) · Clinical Diabetology · doi:10.5603/dk.a2022.0051 · Cited by 6
Wei, M., Cao, W.-B., Zhao, R.-D., Sun, D.-P., Liang, Y.-Z., Huang, Y., Cheng, Z.-W., Ouyang, J., Yang, W.-S., & Yu, W. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i21.3280 · Cited by 6
Liu, X., Dong, M., Li, T., & Wang, J. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156591 · Cited by 6
Rajan, S., Mandikian, D., Baruch, A., Gelzleichter, T. R., Stevens, D. W., Sonoda, J., Cowan, K. J., Boswell, C. A., & Stefanich, E. G. (2017) · mAbs · doi:10.1080/19420862.2017.1373923 · Cited by 6
Bioengineering of FGFs and New Drug Developments
Li, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-816142-5.00008-4 · Cited by 7
Wang, N., Sun, B., Guo, H., Jing, Y., Qi, R., Wang, M., Mi, Y., Chen, H., Song, L., & Cui, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.795520 · Cited by 6
Early Investigational and Experimental Therapeutics for the Treatment of Hypertriglyceridemia
Parthymos, I., Kostapanos, M. S., Liamis, G. L., & Florentin, M. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9020042 · Cited by 6
Acromegaly is associated with high fibroblast growth factor-21 levels
Yürekli, B. Ş., Kutbay, N. Ö., Akşit, M., Süner, A., Şimşir, İ. Y., Seçkiner, S., Kocabaş, G. Ü., Bozkaya, G., & Saygılı, F. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0885-1 · Cited by 6
Nakamura, M., Uehara, Y., Asada, M., Suzuki, M., & Imamura, T. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112463820 · Cited by 6
Genetic Disorders of Phosphate Homeostasis
White, K. E., Bringhurst, F. R., & Econs, M. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00061-7 · Cited by 6
Korkmaz, D., Konya, P. Ş., & Demirtürk, N. (2022) · Turkish Journal of Parasitology · doi:10.4274/tpd.galenos.2022.14633 · Cited by 5
Peng, Z., Gao, L., Zhang, L., Yao, R., Li, X., Deng, L. J., Fan, J., Ying, L., & Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146577 · Cited by 5
The role of fibroblast growth factor 19 in the pathogenesis of nonalcoholic fatty liver disease
Chrysavgis, L., Giannakodimos, I., Chatzigeorgiou, A., Τζιόμαλος, Κ., Papatheodoridis, G., & Cholongitas, Ε. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2127408 · Cited by 5
Miao, X., Peng, C., Yan, F., Guo, X., Xia, L., Song, Q., An, X., & Wu, G. (2024) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.17870 · Cited by 5
Huang, Y., Liu, B., Hu, C., & Lu, Y. (2025) · Protein & Cell · doi:10.1093/procel/pwaf027 · Cited by 4
Meng, J., Chen, X., & Zhu, Y. (2025) · Endocrinology · doi:10.1210/endocr/bqaf176 · Cited by 4
Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic Perspective
Tuokkola, J. E., & Schwertfeger, K. L. (2025) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-025-09594-4 · Cited by 6
Khalil, S. M., de Souza, M. H. G., de Oliveira, F. D., Sato, E. D. B. D. S., & Meine, G. C. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102579 · Cited by 4
Deletion of GFRAL blunts weight lowering effects of FGF21 in female mice
Buch-Rasmussen, A. S., Andersen, H., Stage, C., Hansen, A. M. K., Paulsen, S. J., Gillum, M. P., Andersen, B., Secher, A., Latta, M. R., Clemmensen, C., et al. (2025) · Journal of Endocrinology · doi:10.1530/joe-25-0017 · Cited by 4
The role of alpha-Klotho protein in male and female reproduction. A systematic review
Guedj, N. S., Sokol, P., Quesada‐López, T., Fréour, T., Polyzos, N. P., & Martínez, F. (2024) · F&S Reviews · doi:10.1016/j.xfnr.2024.100084 · Cited by 5
Pelizzo, G., Chiricosta, L., Mazzon, E., Zuccotti, G., Avanzini, M. A., Croce, S., Lima, M., Bramanti, P., & Calcaterra, V. (2021) · Pediatric Reports · doi:10.3390/pediatric13010006 · Cited by 4
Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021
She, Q.-Y., Li, L., Liu, M.-H., Tan, R.-Y., Zhong, Y.-W., Bao, J., & Xie, J.-D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1011008 · Cited by 9
Qureshi, H. A. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000158 · Cited by 4
Zhang, Q., Li, F., Qin, B., Chen, J., Jiang, X., & Zou, S. (2015) · Gene · doi:10.1016/j.gene.2015.07.070 · Cited by 4
The role of β-Klotho in FGF signaling: from molecular insights to therapeutic innovations
Yan, F., Yang, C., Huang, S., Yuan, L., Qiu, Y., Liu, T., Peng, X., & Yang, Y. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00042.2026 · Cited by 4
Szczepańska, E., Glinicki, P., Zgliczyński, W., Slowinska-Srzednicka, J., Jastrzębska, H., & Gietka‐Czernel, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.900034 · Cited by 3
Enhanced bioactivity and stability of a long-acting FGF21: A novel variant for the treatment of NASH
Ji, Y. R., Lu, Q., Duan, Y., Xuan, C., Zhang, Y., Yao, W., Yin, J., & Gao, X. (2024) · Biochimie · doi:10.1016/j.biochi.2024.05.013 · Cited by 3
Multiomics analysis reveals serine catabolism as a potential therapeutic target for MELAS
Liufu, T., Zhao, X., Yu, M., Xie, Z., Meng, L., Lv, H., Zhang, W. Y., Yuan, Y., Xing, G., Deng, J., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302286rrr · Cited by 3
Ruchi Singh Sudha, P. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000371 · Cited by 3
Role of FGF15 in Hepatic Surgery in the Presence of Tumorigenesis: Dr. Jekyll or Mr. Hyde?
Caballeria-Casals, A., Micó-Carnero, M., Rojano-Alfonso, C., Maroto-Serrat, C., Casillas-Ramírez, A., Álvarez‐Mercado, A. I., Gracia‐Sancho, J., & Peralta, C. (2021) · Cells · doi:10.3390/cells10061421 · Cited by 3
Batokine in Central Nervous System Diseases
Shen, M., Zhang, M., Mao, N., & Lin, Z. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03490-w · Cited by 3
Metabolism-related hepatokines change in biliary atresia: ANGPTL6 as a potential biomarker
Fang, D., Hu, S., Tou, J.-F., Dong, F., & Peng, S.-Q. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05675-9 · Cited by 3
Guerrero, J. G., Ishida, E., Shibusawa, N., Lei, X., Yamada, S., Horiguchi, K., & Yamada, M. (2022) · Thyroid · doi:10.1089/thy.2022.0144 · Cited by 3
The FGF Family in Humans, Mice, and Zebrafish: Development, Physiology, and Pathophysiology
Sasaki, S., Ohta, H., Nakajima, Y., Konishi, M., Miyake, A., & Itoh, N. (2011) · InTech eBooks · doi:10.5772/22859 · Cited by 4
Diaz, C., Corentin, H., Thierry, V., Alcouffe, C., Bozec, T., Sibrac, D., Herbert, J., Ferrara, P., Françoise, B., & Ferrán, E. A. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24657 · Cited by 3
Buss, N. A. P. S., Lapointe, J., de Haan, L., Price, S. R., Ahnmark, A., Irving, L. M., Buchanan, A. G., Keyes, F., Davidsson, P., Dixit, R., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.06.033 · Cited by 3
Tacer, K. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-39684-8_6 · Cited by 3
Pharmacology of Gut Hormone Mimetics for Obesity and Diabetes
Lafferty, R. A., O'Harte, F. P. M., Irwin, N., Flatt, P. R., & Gault, V. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00035-9 · Cited by 3
Klotho protein and insulin resistance
Cai, Y., Liu, B., Song, D., Zhao, Y., Xie, B., Zhang, Y., & Zhou, Y. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120840 · Cited by 2
Díaz-Muñoz, C., Bozzarelli, I., Lopera-Maya, E. A., Belbasis, L., Faro, V. L., Tavares, L. C., Heredia-Fernández, F., Lorenzo, B. D., Sinha, T., Blanco, C. E., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337059 · Cited by 2
Wang, Y., Wang, H., Wu, M., Gao, X., Gao, Y., & Zhao, P. (2026) · Journal of Separation Science · doi:10.1002/jssc.70358 · Cited by 2
Brunel, F. M., Parlee, S. D., Li, P., Lu, W., Chabenne, J. R., Pérez–Tilve, D., Finan, B., Kharitonenkov, A., & DiMarchi, R. D. (2026) · Biochemistry · doi:10.1021/acs.biochem.5c00820 · Cited by 2
Lin, Y., Claflin, K. E., Aklan, İ., Morgan, D. A., Sullivan, A. I., Rudolph, M. C., Rahmouni, K., & Potthoff, M. J. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117093 · Cited by 3
Jalan‐Sakrikar, N., Anwar, A. A., Ali, A., Nasser‐Ghodsi, N., Felzen, A., Huebert, R. C., LaRusso, N. F., & O’Hara, S. P. (2026) · Physiological Reviews · doi:10.1152/physrev.00022.2025 · Cited by 5
Novel FGF21 analogues through structure-based optimization for therapeutic development
Guo, Y., Bao, Y., Chen, Z., Rao, Z., Luo, Y., Ye, S., & Liu, S. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024227 · Cited by 2
Vincenzo, A. D., Granzotto, M., Crescenzi, M., Fioretto, P., Vettor, R., & Rossato, M. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01879-3 · Cited by 2
Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis
Yılmaz, Y., Güneş, A., Topel, H., & Atabey, N. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-9958-1 · Cited by 2
Kiyama, G., Nakashima, K., Shimada, K., Murono, N., Kakihana, W., Imai, H., Inoue, M., & Hirai, T. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112078 · Cited by 2
Bile Acids and Their Receptors
Claudel, T., & Trauner, M. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_21 · Cited by 2
FGFR4 (fibroblast growth factor receptor 4)
Peláez‐García, A., Barderas, R., & Casal, J. I. (2012) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/48227 · Cited by 2
Fibroblast growth factor 21: new insights from human studies
Hansen, J. S., & Plomgaard, P. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000084 · Cited by 2
Endocrine fibroblast growth factors and Klotho
Kuro‐o, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818036-5.00007-0 · Cited by 2
Self-citationFibroblast Growth Factor 21 as a Novel Metabolic Regulator
Micanovic, R., Dunbar, J. D., & Kharitonenkov, A. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch14 · Cited by 2
A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
Elsayed, A. (2020) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 2
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00003-2 · Cited by 2
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00004-4 · Cited by 2
Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease
Tanaka, T., Suda, G., Ohara, M., Maehara, O., Yoda, T., Fu, Q., Yang, Z., Yasuura, N., Meno, A., Sasaki, T., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1730695 · Cited by 1
Site-specific bidirectional regulation of Fgf15 transcription in the mouse ileum
Katafuchi, T., Honda, A., & Makishima, M. (2026) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00026.2026 · Cited by 1
Xue, L., Wang, X., & Mao, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1808135 · Cited by 1
The emerging role of the Hippo signaling pathway in interorgan crosstalk
Song, G., Lee, C., & Jho, E. (2026) · FEBS Journal · doi:10.1111/febs.70587 · Cited by 1
Stern, S., Crisamore, K., Patton, J., Schuck, R. N., & Pacanowski, M. A. (2026) · Clinical and Translational Science · doi:10.1111/cts.70634 · Cited by 1
Mansouri, F., Nikooie, R., Mehrtash, M., & Hamidi, M. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112864 · Cited by 2
Holleboom, A. G., & Schattenberg, J. M. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101957 · Cited by 1
Current therapeutic landscape and future treatment perspectives of MASH
Gallage, S., Govaere, O., Anstee, Q. M., Shulman, G. I., Tacke, F., & Heikenwälder, M. F. (2026) · Nature · doi:10.1038/s41586-026-10672-8 · Cited by 4
FGFR1/KLB-MFG-E8 Maintains Microvascular Integrity and Adaptive Cardiac Remodeling
Gare, S. R., Alatawi, N. H. O., Chen, X., Zhang, J., Ross, C. A., Fonseka, O., Han, Y., Kaur, N., Ruiz‐Velasco, A., Zhao, X., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327950 · Cited by 1
Monogenic Phosphate Balance Disorders
Ræder, H., Rafaelsen, S., & Bjerknes, R. (2011) · InTech eBooks · doi:10.5772/17841 · Cited by 1
New Insights into the Roles of Fibroblast Growth Factor 23
Yoshiko, Y., Minamizaki, T., & Maeda, N. (2008) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-008-9008-4 · Cited by 1
Bile Acid as Therapeutic Agents
Yamanashi, Y., Takada, T., & Suzuki, H. (2017) · Springer eBooks · doi:10.1007/978-4-431-56062-3_5 · Cited by 1
The KL genetic polymorphisms Associated with type 2 diabetes Mellitus
Jin, H., & Jung, D. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01057-5 · Cited by 1
Pfaff, M. R., Denburg, M., Meyers, K. E. C., Brady, T. M., Leonard, M. B., Hoofnagle, A. N., & Sethna, C. B. (2023) · American Journal of Nephrology · doi:10.1159/000535092 · Cited by 1
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00001-9 · Cited by 1
Navarro‐González, J. F., Donate‐Correa, J., Muros, M., García-García, P., Getino, M. A., García-Pérez, J., & Fernández, C. M. (2013) · European Journal of Inflammation · doi:10.1177/1721727x1301100108 · Cited by 1
Pathophysiology and Pharmacology of FGFs
Li, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-816142-5.00004-7 · Cited by 1
Evaluation of a cell model expressing βKlotho for screening FGF21 analogues
Guo, X., Wang, X., Yuan, Q., Wu, C., Gao, H., Xu, P., Liu, M., Wang, N., Li, D., & Ren, G. (2019) · Cytotechnology · doi:10.1007/s10616-019-00344-z · Cited by 2
The Metabolic Effects of FGF21: From Physiology to Pharmacology
Song, P. (2020) · JoLS Journal of Life Sciences · doi:10.5352/jls.2020.30.7.640 · Cited by 1
Protein- und Peptid-Hormone von Vertebraten
Kleine, B., & Rossmanith, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-662-58502-3_4 · Cited by 1
Dey, J. H. (2010) · edoc (University of Basel) · doi:10.5451/unibas-005213494 · Cited by 2
Metabolic Health with Obesity: A Novel Role for Cholesteryl Ester Transfer Protein
Cappel, D. A. (2014) · Cited by 1
Bile acids and their receptors
Claudel, T., & Trauner, M. A. (2015) · doi:10.1002/9781118663387.ch28 · Cited by 1
Protein- und Peptid-Hormone von Vertebraten
Kleine, B., & Rossmanith, W. G. (2013) · Springer eBooks · doi:10.1007/978-3-642-37092-2_4
Nelson, B. T. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Studies on cholesterol homeostasis by modulation of lipoproteins and bile acids
Nilsson, L.-M. (2010) · Figshare
Monoclonal Antibodies with Selective Specificity Towards Different Glycosylation Isoforms of FGFR1
Gorbenko, O., Ovcharenko, G. V., Volkova, D., Mayilo, D., Gaman, N., Khozhaenko, Y. V., Usenko, V., Gout, I. T., & Filonenko, V. V. (2009) · Hybridoma · doi:10.1089/hyb.2009.0016
Papel do fósforo e do paratormônio na progressão da doença renal crônica
Magalhães, A. O. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2008.tde-04042008-142314
Audette, D. S. (2024) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/zr28-qz49
Changes in Cardiotrophin-1 and Fibroblast Growth Factor-21 with Weight Loss
Bowers, R. L. (2009)
Potensi Terapeutik Fibroblast Growth Factor 21 terhadap Resistensi Insulin
Kurniasari, K., & Arozal, W. (2015) · eJournal Kedokteran Indonesia · doi:10.23886/ejki.3.5049
Rao, A., Haywood, J., & Dawson, P. A. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9644-0_10
Smallwood, T. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v8q7-2m69
Ding, L., Hao, Z., Yuan, Q., Xu, P., Yu, Y.-H., & Li, D. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3753
Kaniuka‐Jakubowska, S., Biernat, W., & Sworczak, K. (2012)
Harnessing the Action of Fibroblast Growth Factor21 as a Therapeutic Agent
Brunetti, L., & Kagan, L. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0080-7
Rajan, S., Sonoda, J., Tully, T., Williams, A. J., Yang, F., Macchi, F. D., Hudson, T., Chen, M. Z., Liu, S., Valle, N., et al. (2018) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2018.04.002
Expression of the hormonal FGF co‐receptor Klotho beta in the Xenopus laevis model
Chen, G., & Tao, Q. (2018) · Cell Biology International · doi:10.1002/cbin.11059
Buj, D. (2019) · University of Huddersfield Repository (University of Huddersfield)
Metadata
- Authors
- Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- New York University (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 282
- Issue
- 37
- Pages
- 26687-26695
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2496965
- OpenAlex
- W2048411348
- Cited by
- 748
- References
- 35
- Citations by year
- 2026: 37 · 2025: 24 · 2024: 33 · 2023: 31 · 2022: 55 · 2021: 46 · 2020: 44 · 2019: 48 · 2018: 52 · 2017: 47 · 2016: 38 · 2015: 40 · 2014: 43 · 2013: 43 · 2012: 51
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Ellison Medical Foundation
- Welch Foundation
- Ted Nash Long Life Foundation
- Eisai
- National Institutes of Health (1r01ag015326-01, DK067158)
- National Institute on Aging (R01AG19712, R01AG025326, R01 AG 15326, R01AG019712)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-067158, R01DK067158)
- National Institute of Dental and Craniofacial Research (R01DE13686, R01DE013686)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- β-Klotho, Klotho, FGF19, FGF21, fibroblast growth factor 23, fibroblast growth factor receptor, FGFR4, FGFR1, tissue-specific signaling, bile acid metabolism, CYP7A1, hepatocytes, metabolic hormones
- MeSH terms
- Fibroblast Growth Factor-23, Klotho Proteins, Animals, Cholesterol 7-alpha-Hydroxylase, Fibroblast Growth Factors, Humans, Membrane Proteins, Organ Specificity, Phosphorylation, Signal Transduction, Adipocytes, Protein Isoforms, Hepatocytes, 3T3-L1 Cells, Extracellular Signal-Regulated MAP Kinases, Mice, Rats, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
